Abacavir (Ziagen, Triumeq) and Ketamine Therapy | Tovani Health
Ziagen (Abacavir) (also: Epzicom (combo), Triumeq (combo)) — NRTI (HIV)
Verdict at Tovani Health
Fully compatible with KAP; the HLA-B*5701 hypersensitivity screening is intrinsic.
Abacavir and ketamine have no clinically significant interaction. NRTI commonly used as a component of combination HIV therapy (Epzicom = abacavir + lamivudine; Triumeq = abacavir + lamivudine + dolutegravir). The famous safety consideration — abacavir hypersensitivity reaction in patients positive for HLA-B*5701 — is intrinsic, well-known to HIV providers, and requires pre-treatment genetic screening. None of this is KAP-relevant.
If you take Ziagen regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Ziagen interacts with ketamine
Abacavir is a guanosine analog that inhibits HIV reverse transcriptase after intracellular phosphorylation. Hepatic alcohol dehydrogenase and glucuronidation metabolism; no clinically significant CYP interaction with ketamine.
What we do at intake
Continue your HIV regimen. Confirm HLA-B*5701 was checked at initiation (intrinsic).
Bottom line
Abacavir and ketamine have no clinically significant interaction. NRTI commonly used as a component of combination HIV therapy (Epzicom = abacavir + lamivudine; Triumeq = abacavir + lamivudine + dolutegravir). The famous safety consideration — abacavir hypersensitivity reaction in patients positive for HLA-B*5701 — is intrinsic, well-known to HIV providers, and requires pre-treatment genetic screening. None of this is KAP-relevant.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Ziagen (Abacavir) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 23, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.